oral combination of astx727 (decitabine/cedazuridine) plus ven for older/unfit patients with aml
Published 8 months ago • 71 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
1:03
10-day astx727 (decitabine/cedazuridine) with venetoclax in the treatment of r/r aml
-
0:45
oral decitabine/cedazuridine with venetoclax and gilteritinib in patients with aml
-
2:18
the all-oral regimen of decitabine/cedazuridine, venetoclax, & gilteritinib for older pts with aml
-
4:20
updates from a study evaluating astx727 venetoclax for patients with aml
-
1:24
omniverse: safety and tolerability of oral azacitidine plus venetoclax in patients with aml
-
4:14
abionic - the 5-minute d-dimer test handling video
-
25:30
hemolyzer 3 pro
-
32:56
echo analyzer monthly maintenance
-
4:10
astx727 plus venetoclax: phase i study of total oral therapy for high-risk mds/cmml
-
1:51
rationale of omniverse: oral azacitidine venetoclax in patients with r/r or newly diagnosed aml
-
6:21
decitabine and venetoclax for aml
-
2:16
rationale for 10-day decitabine with venetoclax for high-risk aml
-
4:15
phase ib/ii trial of quizartinib, decitabine and venetoclax in flt3-itd-mutated aml
-
1:33
phase i trial results for oral azacitidine and venetoclax in r/r aml
-
0:56
oral decitabine with venetoclax versus oral decitabine alone in hr-mds
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
3:35
onvansertib with cytarabine or decitabine for r/r aml
-
1:27
quizartinib, venetoclax, and decitabine in patients with flt3-itd aml: a phase i/ii trial
-
2:16
allo-sct improves survival following venetoclax and azacitidine therapy in aml
-
4:03
a phase i/ii study evaluating quizartinib plus decitabine and venetoclax in flt3-mutated aml
-
2:43
diagnostic tools for aml